explore -WSS

explore

author：fashion 2025-08-12 08:29:34 - browse：46

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New study raises questions about niacin and heart health

WSS

Congress may force more Covid

The tragedy of Johnson & Johnson’s Covid vaccine

Elizabeth Holmes banned from government health programs

Research misconduct: Proposed new rules face resistance

Test for long Covid? Researchers find new clue in blood samples

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

hotspot

explore

focus

Supreme Court strikes down use of affirmative action

Copay coupons to count toward deductibles, after Biden court move

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Affirmative action in medical school literally saved lives

Congress may force more Covid

ChatGPT in medicine: STAT answers readers' burning questions

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Moonlake's readout produced a cash windfall. Risks remain

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

hotspot

The tragedy of Johnson & Johnson’s Covid vaccine

Flagship Pioneering startup Sonata Therapeutics lays off 21

Eli Lilly, Pfizer, and others want in on the online prescription market

Medicare Advantage enrollment hits roughly 33.4 million

New CMS data security rules will hurt Medicare, Medicaid research

The surgeon had a dilemma only a Nazi medical text could resolve

hotspot

Wikipedia

knowledge

Wikipedia